GSK3B and pancreatic neoplasm: Moreover, Zhou et al.’s study across various pancreatic cancer cell lines highlighted miRNA-744 as a negative prognostic factor, demonstrating its activation of the Wnt/β-catenin pathway by targeting SFRP1 (secreted Frizzled related protein 1) and GSK3β [109].